Brain volume loss in radiologically isolated syndromes compared with early stages of multiple sclerosis patients under DMD treatment

被引：0
|
作者：
Rojas, J. I. [1 ]
Sanchez, F. [1 ]
Caro, F. [1 ]
Miguez, J. [1 ]
Patrucco, L. [1 ]
Cristiano, E. [1 ]
机构：
[1] Hosp Italiano Buenos Aires, Ctr Esclerosis Multiple Buenos Aires, Buenos Aires, DF, Argentina
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P854
引用
收藏
页码：440 / 441
页数：2
相关论文
共 50 条
  • [31] Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics
    Vidal-Jordana, Angela
    Sastre-Garriga, Jaume
    Perez-Miralles, Francisco
    Pareto, Deborah
    Rio, Jordi
    Auger, Cristina
    Tintore, Mar
    Rovira, Alex
    Montalban, Xavier
    JOURNAL OF NEUROIMAGING, 2016, 26 (05) : 532 - 538
  • [32] Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes
    Dalton, CM
    Chard, DT
    Davies, GR
    Miszkiel, KA
    Altmann, DR
    Fernando, K
    Plant, GT
    Thompson, AJ
    Miller, DH
    BRAIN, 2004, 127 : 1101 - 1107
  • [33] Predicting early conversion to multiple sclerosis in patients with clinically isolated syndromes: the importance of an integrated modeling of risk factors
    Martinelli, V.
    Dalla Costa, G.
    Moiola, L.
    Rodegher, M.
    Colombo, B.
    Di Maggio, G.
    Leocani, L.
    Furlan, R.
    Filippi, M.
    Comi, G.
    JOURNAL OF NEUROLOGY, 2014, 261 : S134 - S134
  • [34] Predicting early conversion to multiple sclerosis in patients with clinically isolated syndromes: the importance of an integrated modeling of risk factors
    Martinelli, V.
    Costa, G. Dalla
    Moiola, L.
    Rodegher, M.
    Colombo, B.
    Di Maggio, G.
    Leocani, L.
    Furlan, R.
    Filippi, M.
    Comi, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 192 - 192
  • [35] Predicting early conversion to multiple sclerosis in patients with clinically isolated syndromes: the importance of an integrated modeling of risk factors
    Martinelli, V.
    Dalla Costa, G.
    Colombo, B.
    Di Maggio, G.
    Furlan, R.
    Leocani, L.
    Filippi, M.
    Comi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 43 - 44
  • [36] Cladribine effect on brain volume loss and its correlation with disability progression in patients with relapsing multiple sclerosis
    de Stefano, N.
    Giorgio, A.
    Battaglini, M.
    De Leucio, A.
    Giovannoni, G.
    Hicking, C.
    Dangond, F.
    Sormani, M. P.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 216 - 217
  • [37] Effect of oral fingolimod treatment on brain volume loss in patients with relapsing-remitting multiple sclerosis estimated using Bayesian methodology
    Yin, Guosheng
    Meng, Xiangyi
    Islam, M. Zahur
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 69 - 70
  • [38] Effect of oral fingolimod treatment on brain volume loss in patients with relapsing- remitting multiple sclerosis estimated using Bayesian methodology
    Yin, Guosheng
    Meng, Xiangyi
    Islam, M. Zahur
    NEUROLOGY, 2017, 88
  • [39] Brain volume loss in relapsing multiple sclerosis: indirect treatment comparisons of available disease-modifying therapies
    Zivadinov, Robert
    Keenan, Alexander J.
    Le, Hoa H.
    Ait-Tihyaty, Maria
    Gandhi, Kavita
    Zierhut, Matthew L.
    Salvo-Halloran, Elizabeth M.
    Ramirez, Abril Oliva
    Vuong, Vivian
    Singh, Sumeet
    Hutton, Brian
    BMC NEUROLOGY, 2024, 24 (01)
  • [40] Brain volume loss during the first year and physical and cognitive impairment over 3 years in naive multiple sclerosis patients under fingolimod
    Rojas, J.
    Sanchez, F.
    Patrucco, L.
    Papolla, A.
    Miguez, J.
    Cristiano, E.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 518 - 519
12345